Legacy Education Inc. (LGCY) Q1 2026 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call revealed strong financial performance with a 38.5% revenue growth and a 9.6% increase in EBITDA, despite margin decline due to strategic investments. The Q&A section highlighted a robust acquisition pipeline and strategic capacity planning. Although management was vague on certain details, overall sentiment was positive due to strong enrollment momentum, new program launches, and strategic partnerships. This suggests a likely positive stock price movement in the short term.
Key Financial Performance
Revenue Revenue grew 38.5% to $19.4 million, driven by a 31.6% increase in new student starts to 1,117 and a 37.7% rise in ending student population to 3,495. This growth represents the 13th consecutive quarter of double-digit revenue growth, attributed to strong demand and successful enrollment initiatives.
Adjusted EBITDA Adjusted EBITDA rose 9.6% to $3.1 million, with a margin of 15.9%. The year-over-year decline in margin reflects deliberate front-loaded investments in growth and nonrecurring charges.
Net Income Net income increased 4.6% to $2.2 million. Diluted EPS was $0.16 compared to $0.21 last year, impacted by the increase in diluted shares from 9.8 million to 13.9 million following the September '24 IPO. On a normalized share count, EPS would have been $0.22, demonstrating the underlying strength of earnings.
Accounts Receivable Reserve A $178,000 reserve was recorded this quarter, representing 0.9% of revenue, consistent with expectations. This follows a $700,000 reserve in Q4 of fiscal '25 for graduated borrowers who had fallen behind on payments. The company has enhanced its collections process, leading to stabilizing delinquency trends and improved collections.
Effective Tax Rate The effective tax rate was 26.5%, better than the annual estimated 29.4%. This improvement was tied to employee stock option exercises following the IPO.
Educational Services Expense Educational service expenses rose to 53.2% of revenue from 51.4%, reflecting investments in clinical quality, hands-on training, and new program approvals.
General and Administrative Expenses G&A expenses increased to 31.5% of revenue from 28.3%, driven by professional services, audit, legal, compliance, and M&A-related valuations, as well as marketing investments and D&O insurance. These are strategic investments in capacity, compliance, and market reach.
Operating Cash Flow Operating cash flow was positive but lower year-over-year due to the timing of Federal Title IV disbursements, unrelated to the government shutdown. Student collections remain strong and growing.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
New Programs: Four new programs approved, including three degree programs (MRI, Cardiac Sonography, Surgical Technology) and one certificate program (Sterile Processing).
Program Expansion: Investments in curriculum development, regulatory approvals, faculty recruitment, and facility upgrades for new programs.
Enrollment Growth: 31.6% increase in new student starts to 1,117 and a 37.7% rise in ending student population to 3,495, reflecting strong demand.
Sector Demand: High demand for skilled healthcare professionals in fields like nursing, medical assisting, and sonography due to structural shortages.
Revenue Growth: Revenue grew 38.5% year-over-year to $19.4 million, marking the 13th consecutive quarter of double-digit revenue growth.
Operational Investments: Strategic investments in marketing, compliance, and professional development to support growth and program quality.
M&A and Compliance: Focus on accretive M&A opportunities and maintaining compliance as a competitive advantage in a regulated environment.
Hybrid Model and Innovation: Advancing hybrid delivery models with simulation technology and clinical partnerships to enhance outcomes.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Accounts Receivable and Delinquency Trends: The company recorded a $700,000 reserve for graduated borrowers who had fallen behind on payments in Q4 of fiscal '25. While delinquency trends are stabilizing, the company is still actively managing collections and has partnered with a collection company to address this issue. This poses a risk to cash flow and financial stability if not managed effectively.
Educational Service Expenses: Educational service expenses rose to 53.2% of revenue from 51.4%, reflecting increased costs for program enhancements, new hires, and externship fees. This could pressure margins if revenue growth does not keep pace with these investments.
General and Administrative (G&A) Expenses: G&A expenses increased to 31.5% of revenue from 28.3%, driven by higher costs for audit, legal, compliance, and M&A-related valuations. These non-recurring costs could impact short-term profitability.
Regulatory and Compliance Risks: The company operates in a highly regulated environment, and compliance is critical. Any lapses in regulatory adherence could disrupt operations and funding, posing a significant risk to the business.
Title IV Disbursement Timing: Operating cash flow was impacted by the timing of Federal Title IV disbursements, which is tied to enrollment cycles and regulatory processing. This could create short-term liquidity challenges.
New Program Investments: The company has made front-loaded investments in new programs, including curriculum development, faculty recruitment, and facility upgrades. While these are strategic, they could strain financial resources if the programs do not generate expected returns.
Economic and Workforce Challenges: The company is addressing structural demand for healthcare professionals, but economic uncertainties and workforce challenges at the federal level could impact enrollment and program funding.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Growth: The company expects sequential margin improvement as investments mature and revenue scales. Revenue grew 38.5% to $19.4 million in Q1 2026, driven by a 31.6% increase in new student starts and a 37.7% rise in ending student population.
New Program Launches: Four new programs have been approved, including degree programs in MRI, cardiac sonography, surgical technology, and a certificate in sterile processing. These programs are expected to contribute to future revenue growth.
Operational Innovation: The company is advancing its hybrid model delivery with simulation technology and clinical partnerships to improve outcomes.
Compliance and Regulatory: The company remains compliant across all jurisdictions and expects no disruptions to funding or program delivery. Title IV disbursements are expected to normalize in future quarters.
Market Demand: The company is capitalizing on structural demand for healthcare professionals, with over 200,000 nursing openings annually through 2031 and growing shortages in medical assisting, sonography, and sterile processing.
Strategic Investments: Investments in curriculum development, faculty recruitment, simulation labs, and facility upgrades are expected to drive long-term growth. Margins are expected to expand sequentially throughout the year.
M&A Opportunities: The company is leveraging its $20.6 million in cash to evaluate accretive M&A opportunities to further expand its market reach.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
The selected topic was not discussed during the call.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide details about the 4 new programs that started in October, including their capacity over the next few quarters?
A:The 4 new degree-granting programs started in the second quarter, with each program enrolling 20 to 24 students per session. These programs can run both in the morning and evening. The results of these programs will be realized in Q2, Q3, and beyond.
Q:How many students were added incrementally by the 4 new programs?
A:No students were added to the Q1 results from these programs. The impact will be seen in Q2 and Q3.
Q:How is the acquisition pipeline looking? Are you spending more or less time on acquisitions?
A:The acquisition pipeline remains strong, with several opportunities elevated to the Board level. The company is targeting both single and multi-campus acquisitions within and outside California. They are on track to announce the next acquisition within this fiscal year.
Q:Are you nearing capacity constraints with existing buildings and facilities? What is the total student population capacity?
A:Some campuses have a capacity of 700 to 800 students. Lease renewals and expansions are being planned to align with future capacity needs. Hybrid program delivery helps manage capacity, as students complete the first 6 to 9 months of general education courses online before attending campus for laboratory interactions.
Q:Can you provide details about the placement side of Legacy? Is Legacy in touch with ASCs, physician offices, and hospitals directly?
A:Legacy continues to add clinical and external placements by partnering with local facilities, hospitals, and healthcare systems like RadNet, Sharp, and Scripps. These partnerships are based on the needs of these facilities, and graduates are hired directly by them.
Q:Are you currently placing students outside of the state or outside the U.S.?
A:Legacy has minimal experience placing students outside the U.S., with a few instances in Canada. Students are not typically placed outside California unless they transfer out after completing their education. The company is exploring greenfielding opportunities outside California.
Q:Review of Unclear Management Responses
A:Management avoided providing specific numerical details about the incremental student additions from the 4 new programs and the exact timing of the next acquisition announcement. Additionally, the response about placing students outside the U.S. and California lacked clarity and detail.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
ADN program
AI
AR
Applied Science
Associate Applied
Cash
College Lancaster
Desert Medical
GA
Health
High Desert
IPO
IV disbursement
activity
advantage
balance sheet
benefit
care
cash flow
collection
debt
diagnostics
improvement
increase percentage
margin
nursing
period
precision
processing
program approval
projection
quality
reserve
student population
tax rate
timing
LGCY Transcript
Legacy Education Inc. (LGCY) Q3 2026 Earnings Call Transcript
Positive5-14
The earnings call summary reveals strong financial performance, with significant revenue growth, increased net income, and improved operating margins. These positive financial metrics suggest effective cost management and operational efficiency, which are likely to boost investor confidence. The lack of discussion on operational updates, strategic initiatives, and returns is mitigated by the robust financial results. Despite acknowledging risks in forward-looking statements, the overall sentiment leans positive due to the impressive financial achievements.
Legacy Education Inc. (LGCY) Q2 2026 Earnings Call Transcript
Positive2-12
The earnings call indicates strong financial performance with revenue and net income growth, effective cost management, and strong liquidity. New program launches and strategic investments suggest future growth potential. The Q&A section revealed robust enrollment and program expansion, with positive sentiment from analysts. Despite some vague responses, the overall outlook remains optimistic. Additionally, the company is exploring M&A opportunities to expand its market reach. Considering these factors, the stock price is likely to see a positive movement over the next two weeks.
Legacy Education Inc. (LGCY) Q1 2026 Earnings Call Transcript
Positive11-13
The earnings call revealed strong financial performance with a 38.5% revenue growth and a 9.6% increase in EBITDA, despite margin decline due to strategic investments. The Q&A section highlighted a robust acquisition pipeline and strategic capacity planning. Although management was vague on certain details, overall sentiment was positive due to strong enrollment momentum, new program launches, and strategic partnerships. This suggests a likely positive stock price movement in the short term.
Legacy Education Inc. (LGCY) Q4 2025 Earnings Call Transcript
Positive9-25
The earnings call revealed strong financial performance with significant revenue and net income growth. Despite some concerns about enrollment dependence and economic uncertainties, management demonstrated operational efficiency and a robust balance sheet. The Q&A highlighted capacity expansions and new program launches, though management was cautious with forward guidance. Overall, the positive financial metrics and strategic expansions suggest a positive stock price movement.
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
